Not exact matches
Katherine High, Spark's president and chief scientific officer, expressed her enthusiasm for the early clinical data related to SPK - 8011: «The encouraging start of our SPK - 8011 clinical trial reinforces the strength of our
gene therapy platform, delivers
human proof - of - concept in a second liver - mediated disease — a significant achievement in the
gene therapy field — and positions us well to potentially transform the current
treatment approach for this life - altering disease with a one - time intervention.»
These
human genes were also protective against alpha - synuclein - induced death, suggesting that they could be worth testing as
gene therapy treatments for Parkinson's disease, Lu says.
This study represents a significant step towards the development of clinical trials in
gene therapy for the curative
treatment of hereditary deafness and balance loss in
humans.
The SMA model pig was created using a
gene therapy approach by knocking down the levels of pig SMN, followed by
treatment with
human SMN at early and late time points.
The research, part of a phase I clinical trial to test the safety of the
treatment, was published as a letter to the editor in The New England Journal of Medicine earlier this week and will be in the September issue of
Human Gene Therapy.
The goal of the Program in
Human Gene Therapy is to develop gene transfer technologies and use them for hepatic gene therapy for the treatment of genetic and acquired disea
Gene Therapy is to develop gene transfer technologies and use them for hepatic gene therapy for the treatment of genetic and acquired di
Therapy is to develop
gene transfer technologies and use them for hepatic gene therapy for the treatment of genetic and acquired disea
gene transfer technologies and use them for hepatic
gene therapy for the treatment of genetic and acquired disea
gene therapy for the treatment of genetic and acquired di
therapy for the
treatment of genetic and acquired diseases.
A new animal study involving virally - delivered
gene therapies has indicated that high
treatment doses might not be as safe as previous
human trials have suggested
«Our work in NPC1 mice may help lead to
human clinical trials and eventually FDA approval for
gene therapy as a
treatment for NPC1 disease,» said Charles P. Venditti, M.D., Ph.D., senior investigator in the NHGRI Medical Genomics and Metabolic Genetics Branch.
Auburn University College of Veterinary Medicine, UMass Medical School to test
gene therapy treatment for Tay - Sachs and Sandhoff diseases Researchers at Auburn University College of Veterinary Medicine and UMass Medical School are nearing
human clinical trials on a genetic
therapy for two rare neurological diseases that are fatal to children.